A recently approved twice-yearly injection to prevent HIV may warrant a higher price, but thousands of dollars more?  CVS Caremark’s chief medical officer calls on Gilead Sciences to lower the $28,000 ...
In a first, Colorado will cap the price of Enbrel, an arthritis drug. Using patent tactics, the drugmaker Amgen has ...
Government agreement with IVF drug manufacturer drops price in exchange for tariff reductions, expedited FDA approval ...
Whether you deal with constant soreness in your knee or just want some additional support when out for a run or at the gym, ...
Californians will be able to buy five packs of insulin pens for a maximum of $55 per pack, or $11 per pen, starting Jan. 1, ...
Cytopoint injection costs vary based on the size of your dog but can run anywhere from $50 to $200 or more. Cytopoint is a long-lasting, injectable treatment for dogs suffering from itchy, inflamed ...
The Bassett Healthcare Network has announced a regenerative and non-operative therapy for muscle, joint, and tendon injuries or issues is now being offered at Cobleskill Regional Hospital. According ...
Initial and follow-up 3D digital scans provide new insights into the effects of hyaluronic acid (HA) fillers in restoring facial volume and fullness, reports a study in the October issue of Plastic ...
Tirzepatide appears more cost-effective than semaglutide for obesity and knee osteoarthritis, though long-term data and patient-centered outcomes remain key. Tirzepatide was found to be more ...
Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of ...
Usual care provided 9.59 QALYs at a lifetime cost of $222,300, diet and exercise yielded 9.75 QALYs for $226,300, and semaglutide offered 10.48 QALYs at $273,500, with tirzepatide providing 10.68 ...
Tirzepatide demonstrated superior cost-effectiveness compared to semaglutide for knee OA and obesity, with a $57,400 per QALY threshold. The Osteoarthritis Policy Model assessed cost-effectiveness, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results